Denodo’s 2020 User Conference DataFest Draws a Record 1,800 Global Attendees Exploring Hybrid/Multi-Cloud, Cloud Integration, Data Fabric, Data Science & AI/ML
17.12.2020 11:00:00 EET | Business Wire | Press release
Denodo, the leader in data virtualization, today announced a record attendance of nearly 1,800 at its annual user conference, DataFest 2020 which was held across the NA, EMEA, and APAC regions. This year’s virtual DataFest events hosted some of the most well recognized data luminaries and subject matter experts, who immersed themselves in topics such as hybrid/multi-cloud strategies, cloud data integration, data science and AI/ML, among others. Attendees made up of Denodo customers, partners, and analysts chose the winners of Denodo’s annual Data Innovation Awards at each event, to recognize some of the exemplary use cases of logical data fabric created with data virtualization technology as the foundation.
All of the session presentations are now available for on-demand viewing, here.
“Our heartiest congratulations go out to all the winners and finalists of our Data Innovation Awards,” said Ravi Shankar, senior vice president and chief marketing officer at Denodo. “Recognizing these customers is the least we can do, as these organizations and individuals set the standard for the future of data management and exemplify some of the best use cases of logical data fabric. As we push the envelope with continuous product innovations, our customers showcased how those advancements can be put to work for even more impressive and valuable use cases.”
Like past events, this year included an esteemed panel of subject matter experts, who distilled through a slew of customer use cases to choose the finalists for each Data Innovation Award. All Denodo customers were considered for the Data Innovation Award with the winners acknowledged for demonstrating best practices, business impact, and novel implementations. The selection process highlights the many innovative uses of data virtualization at actual customer sites and provided attendees with metrics to validate its importance.
“I am absolutely thrilled to receive this year’s Data Innovation Award for the EMEA region,” said Olav Lognvik, Solution Architect at DNB. “Denodo has been the central piece in our cutting-edge data platform that supports data science use cases such as the one for mobile banking. We are glad to be able to share our success story with hundreds of data virtualization enthusiasts and as we broaden our use cases of the Denodo Platform, we hope to share more success stories in the future.”
Winners and finalists of the Denodo Data Innovation Awards 2020 include:
North America – Winner Lauren Cordova from Panasonic, for its connected car IoT/Edge and cloud analytics use case; finalist Ryan Thompson from Prologis, for their logical data lake use case.
EMEA – Winner Olav Lognvik and Christian Dancke Tuen from DNB, for its data science for mobile banking use case; finalist Tekin Mentes from LeasePlan, for their global data hub for fleet management use case.
APAC – Winner Joshua Fletcher from BHP, for its multi-cloud data fabric for global resource management use case; finalist Johan De Coning from Silver Chain, for their Healthcare with hololens and incident management system use case.
Please tweet: News: #datavirtualization leader Denodo announces the winners of its 3rd annual Data Innovation Awards during #DenodoDataFest 2020. Audience vote @Panasonic, @BHP and @DNB for the most innovative use cases.
About Denodo
Denodo is the leader in data virtualization providing agile, high performance data integration, data abstraction, and real-time data services across the broadest range of enterprise, cloud, big data, and unstructured data sources at half the cost of traditional approaches. Denodo’s customers across every major industry have gained significant business agility and ROI by enabling faster and easier access to unified business information for agile BI, big data analytics, Web, cloud integration, single-view applications, and enterprise data services. Denodo is well-funded, profitable, and privately held. For more information, visit http://www.denodo.com or call +1 877 556 2531 / +44 (0) 20 7869 8053.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20201217005044/en/
Contact information
Chris McCoin or Richard Smith
McCoin & Smith Communications Inc.
508-429-5988 (Chris) or 978-433-3304 (Rick)
chris@mccoinsmith.com or rick@mccoinsmith.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
OXMIQ Raises $35 Million to Scale OxCore™ Architecture1.7.2026 16:15:00 EEST | Press release
OXMIQ Labs Inc., a unified GPU and AI architecture company founded by Raja Koduri, today closed its $35 million Series A financing, bringing the company’s total capital raised to $60 million. The funding will scale OxCore™, OXMIQ’s licensable GPU architecture that allows semiconductor companies and AI system builders to build custom AI silicon without a full chip program. The round was co-led by Fundomo and Samsung Catalyst Fund, with participation from MediaTek, AM Intelligence Labs, Pegatron Venture Capital, CDIB-TEN, Darwin Ventures, and Morgan Creek Digital, among other financial and strategic investors. OXMIQ’s expertise spans the full AI stack, from renewable power and data center infrastructure to silicon IP, electron-to-token machines (ETMs™), along with the software that runs AI factories and agents. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260701241910/en/ OXMIQ Funding raised to date of $60M after current $3
SamanTree Medical’s Histolog ® Scanner Technology Featured in 13 Publications in Special BJU International Issue on Confocal Microscopy in Urology1.7.2026 16:01:00 EEST | Press release
SamanTree Medical, a global leader in surgical imaging innovation, today announced that Histolog Scanner confocal microscopy technology has been featured in 13 peer-reviewed clinical papers in a special issue of BJU International, one of the world’s leading journals in urology. The special edition focuses on a growing body of evidence of the role of confocal microscopy in urologic surgery. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260701425845/en/ SamanTree Medical announces that Histolog® Scanner confocal microscopy technology is featured in 13 peer-reviewed clinical papers in a special issue of BJU International. “The special issue represents increasing momentum behind confocal microscopy in urologic surgery,” said Professor Greg Shaw, consultant urologic surgeon at University College London Hospitals (UCLH) and author of several studies in the special issue. “This collection, ranging from radical prostatectomy to eme
Regnology to Acquire Fed Reporter, Accelerating U.S. Leadership and Advancing Regulatory Modernization1.7.2026 16:00:00 EEST | Press release
Regnology, a leading provider at the intersection of regulatory, risk, and supervisory technology, today announced it has entered into a definitive agreement to acquire Fed Reporter, the market-leading U.S. provider of regulatory reporting solutions for financial institutions of all sizes, including banks, credit unions, and bank holding companies. The acquisition marks a pivotal milestone in Regnology’s U.S. expansion, creating the most comprehensive regulatory reporting coverage across the American financial landscape and extending its reach to more than 4,000 institutions from global banks to community lenders. By combining a proven, cloud-first, agentic-first technology foundation with deeply embedded local expertise, Regnology is uniquely positioned to support more efficient, transparent, and data-driven reporting, while strengthening alignment between financial institutions and supervisory authorities. “This is the next step in our U.S. strategy,” said Rob Mackay, CEO of Regnolog
Xsolla Announces Scholarship Program to Support Emerging Developers1.7.2026 16:00:00 EEST | Press release
Xsolla, a leading global video game commerce company, today announced the launch of the Xsolla Developer Scholarship Program - Cologne 2026 an initiative designed to support independent and mid-tier game developers who face financial barriers to attending gamescom 2026 in Cologne, Germany. As the world’s largest gaming event, gamescom brings together developers, publishers, investors, and industry leaders from across the globe to explore new opportunities, showcase innovative projects, and build meaningful business relationships. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260701200418/en/ Graphic: Xsolla The developer scholarship program is designed to help promising studios and independent creators gain access to one of the industry’s most influential events by providing professional development and networking opportunities to accelerate their growth and success. Building on Xsolla’s commitment to supporting game creato
AGC Pharma Chemicals Validates Facilities for CDMO Services via Scientist.com’s VERIF.i ® Program1.7.2026 14:55:00 EEST | Press release
Scientist.com, the life sciences industry’s leading AI-enabled R&D orchestration platform and digital marketplace, and AGC Pharma Chemicals, a leading global Contract Development and Manufacturing Organization (CDMO) for small molecule API and HPAPI, announced today that AGC has successfully completed an onsite assessment of its new Barcelona facility using the VERIF.i® supplier pre-assessment program. The newly expanded Barcelona site strengthens AGC’s position as a global leader in the development and commercialization of complex small molecule Active Pharmaceutical Ingredients (APIs) and highly potent APIs (HPAPIs). Designed for maximum flexibility, safety, and energy efficiency, the facility expands AGC’s end-to-end capabilities from gram-scale to ton-scale production under the highest quality and sustainability standards. “At AGC Pharma Chemicals, we place the highest priority on the integrity of our operational processes and the expertise of our frontline teams,” said Jun Kurihar
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom